Arbital Health, a healthcare technology company that provides critical infrastructure for providers and payers to successfully manage risk-based contracts, today announced a $31 million Series B funding round led by Valtruis, with participation from existing investors Transformation Capital, Shaper Capital, and Healthy Ventures. The investment will expand Arbital Health's payer and provider facing capabilities and accelerate value-based care contract performance monitoring, management and reconciliation across all major risk models. In addition, the new funds will be used to grow Arbital Health's market-leading actuarial team and expand the company's AI-powered platform that helps providers and payers deliver on their promise of better patient outcomes and sustainable financial performance.

Arbital Health provides the critical infrastructure for providers and payers to successfully manage risk-based contracts. With the industry's leading value-based actuaries and robust AI-powered platform, Arbital Health accelerates contract performance monitoring and decision-making, centralizes fragmented data, and automates contract reconciliation across all major risk models. By reducing complexity and administrative burden, Arbital Health ensures value-based care contracts deliver on their promise of better patient outcomes and sustainable financial performance.